I’ve been following an interesting crowd-funding effort for a woman with metastatic cervical cancer Caring for Christine. The funding is to help her pay for treatment at a facility outside the USA, where she is receiving IV therapy called CK3, which refers to VitC plus a form of VitK (VitK3, aka menadione). It appears this facility also adds insulin to the infusion. According to info on the crowd-funding site, this woman is making a remarkable recovery…at least so far.
The proposed mechanism of CK3 is similar to that proposed for just IVC alone (i.e. it induces peroxide production that kills cancer cells). But it further is proposed that adding a small amount of VitK3, due to redox cycling with oxygen and ascorbate, results in much faster ascorbate oxidation and therefore much greater amounts of peroxide. But why add insulin to the mix?
The oxidation of ascorbate produces dehydroascorbic acid. This DHAA is transported into cells by glucose transporters. High blood glucose competes for the transporters, so the cells cannot absorb as much DHAA. One way to enhance the absorption of DHAA during this therapy would be to lower blood glucose by administering insulin simultaneously. I’ve previously expressed on this forum my hypothesis that DHAA and peroxide behave synergistically in killing cancer cells viewtopic.php?p=41985#p41985 The inclusion of insulin by this particular facility suggests to me that they may also recognize this synergism.